• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Former Stryker marketing executive escapes jail sentence | Medtech Wall Street news for the week of Apr. 21, 2014

Former Stryker marketing executive escapes jail sentence | Medtech Wall Street news for the week of Apr. 21, 2014

April 24, 2014 By MassDevice Contributors Network

Ex-Stryker exec dodges jail in insider trading scheme

April 17, 2014 by Brad Perriello

Ex-Stryker exec dodges jail in insider trading scheme

A former Stryker marketing executive escaped a jail sentence yesterday, instead drawing 6 months of home confinement and 2 years of probation for passing along inside information ahead of Stryker’s 2011 acquisition of Orthovita.

Last week a pair of traders were sentenced to jail for their parts in the scheme, after admitting to illegal stock trades based on tips relayed from Mark Foldy, a former marketing executive at Stryker. Read more

GE Healthcare's Q1 sales, profits slide

April 17, 2014 by Brad Perriello

GE Healthcare's Q1 sales, profits slide

GE Healthcare saw its sales and profits decline by single digits during the 1st quarter due to "market volatility.

GE Healthcare posted profits of $570 million on sales of $4.20 billion for the 3 months ended March 31, for a bottom-line decline of 4.2% and a top-line slide of 2.1% compared with the same period last year. Read more

Vital Therapies aims even lower with $12-per-share IPO | MassDevice.com On Call

April 18, 2014 by Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — California biotherapeutics company Vital Therapies dropped its per-share price even lower, opening today at $12 per share in the hopes of raising $54 million. Shares are slated to open today on the Nasdaq market under the symbol "VTL."

Vital Therapeutics plans to use the new funds to support upcoming clinical trial efforts, according to an SEC filing. The company plans use some of its existing cash and equivalents to make up the difference, should the IPO fail to bring in enough to cover costs. Read more

Baxter blows away Wall Street as renal sales surge in Q1

April 17, 2014 by Arezu Sarvestani

Baxter blows away Wall Street with dialysis sales surge in Q1

Illinois healthcare titan Baxter isn’t getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.

The company’s stock was down 0.6% to $72.97 as of about 12:05 p.m. EST following reports that Q1 adjusted EPS came in 9¢ higher than projected. The boost was reported alongside a 14.6% increase in sales and a modest 0.7% increase in profits for the 3 months ended March 31. Read more

Cardiac Dimensions closes $20M equity round

April 17, 2014 by Brad Perriello

Cardiac Dimensions closes $20M equity round

Cardiac Dimensions said it raised $20 million from a syndicate of international investors for its Carillon mitral valve implant.

M.H. Carnegie & Co. and Lumira Capital led the round for Kirkland, Wash.-based Cardiac Dimensions, according to a press release. Investors in Australia, the U.S. and Canada also participated, the company said. Read more

Filed Under: News Well, Wall Street Beat Tagged With: Baxter, Cardiac Dimensions Inc., GE Healthcare, Stryker, Vital Therapies

More recent news

  • Smith+Nephew to open first orthopedic ambulatory surgery center in the UK
  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy